We are live on ! Find out more
Group One Trading

Group One Trading Portfolio holdings

AUM $52.2B
1-Year Est. Return 104.56%
This Fund
S&P 500
This Quarter Est. Return
+12.98%
1 Year Est. Return
+104.56%
3 Year Est. Return
+314.05%
5 Year Est. Return
+338.55%
10 Year Est. Return
+1,999.92%
AUM
$9.21B
AUM Growth
+$762M
Cap. Flow
+$86.4M
Cap. Flow %
0.94%
Top 10 Hldgs %
10.76%
Holding
5,470
New
864
Increased
1,681
Reduced
1,705
Closed
949

Sector Composition

Rank Sector Weight
1 Healthcare 3.15%
2 Materials 1.9%
3 Technology 1.65%
4 Consumer Discretionary 1.6%
5 Energy 1.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RARE icon
2126
CALL
Ultragenyx Pharmaceutical
RARE
$2.55B
$277K ﹤0.01%
3,900
+3,800
+3,800% +$243K
PFPT
2127
CALL
DELISTED
Proofpoint, Inc.
PFPT
$277K ﹤0.01%
3,700
-100
-3% -$7.38K
BBG
2128
PUT
DELISTED
Bill Barrett Corp
BBG
$277K ﹤0.01%
49,900
+7,300
+17% +$43.4K
IFN
2129
PUT
Aberdeen India Fund
IFN
$504M
$276K ﹤0.01%
11,100
-300
-3% -$7.58K
DGI
2130
CALL
DELISTED
DigitalGlobe Inc.
DGI
$275K ﹤0.01%
+10,000
New +$256K
TVPT
2131
CALL
DELISTED
Travelport Worldwide Limited
TVPT
$274K ﹤0.01%
18,200
+8,100
+80% +$111K
EGIO
2132
CALL
DELISTED
Edgio, Inc. Common Stock
EGIO
$273K ﹤0.01%
3,650
+3,400
+1,360% +$230K
DERM
2133
DELISTED
Dermira, Inc.
DERM
$273K ﹤0.01%
8,069
-1,635
-17% -$52.7K
TBPH icon
2134
CALL
Theravance Biopharma
TBPH
$878M
$272K ﹤0.01%
+7,500
New +$209K
CSCI
2135
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$272K ﹤0.01%
793
+250
+46% +$87.6K
ENZ
2136
CALL
DELISTED
Enzo Biochem, Inc.
ENZ
$272K ﹤0.01%
53,500
+11,400
+27% +$68.1K
AKBA icon
2137
Akebia Therapeutics
AKBA
$252M
$271K ﹤0.01%
29,891
+5,389
+22% +$45.8K
BPOP icon
2138
Popular Inc
BPOP
$11.1B
$271K ﹤0.01%
7,100
+5,000
+238% +$178K
P
2139
CALL
Everpure Inc
P
$29.8B
$271K ﹤0.01%
20,000
-9,300
-32% -$116K
PE
2140
CALL
DELISTED
PARSLEY ENERGY INC
PE
$271K ﹤0.01%
8,100
-8,600
-51% -$269K
KITE
2141
DELISTED
Kite Pharma, Inc.
KITE
$271K ﹤0.01%
+4,847
New +$270K
EZPW icon
2142
PUT
Ezcorp Inc
EZPW
$1.72B
$270K ﹤0.01%
24,400
+21,200
+663% +$205K
INFO
2143
CALL
DELISTED
IHS Markit Ltd. Common Shares
INFO
$270K ﹤0.01%
+7,200
New +$257K
LXRX icon
2144
Lexicon Pharmaceuticals
LXRX
$1.07B
$269K ﹤0.01%
14,870
-900
-6% -$14.5K
DAR icon
2145
Darling Ingredients
DAR
$9.44B
$267K ﹤0.01%
19,786
+5,768
+41% +$83.2K
SVC
2146
Service Properties Trust
SVC
$1.06B
$267K ﹤0.01%
+1,798
New +$274K
ARCT icon
2147
Arcturus Therapeutics
ARCT
$213M
$266K ﹤0.01%
15,404
-14,043
-48% -$454K
HES
2148
DELISTED
Hess
HES
$266K ﹤0.01%
4,963
-778
-14% -$41.7K
ZD icon
2149
CALL
Ziff Davis
ZD
$2.05B
$266K ﹤0.01%
+4,600
New +$268K
PRMW
2150
CALL
DELISTED
Primo Water Corporation
PRMW
$266K ﹤0.01%
+18,700
New +$287K

Similar funds

Group One Trading's Q3 2016 Portfolio in Review

As of Q3 2016, Group One Trading held 5,470 positions worth $9.21B, up 9% from $8.45B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Group One Trading's Q3 2016 filing shows 864 new, 1,681 increased, 1,705 reduced and 949 closed positions. Its largest new stake was Pfizer: 313,934 shares worth $10.1M. The largest sale was Allergan plc, an estimated $28.1M.

By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.8% a quarter earlier, followed by Materials and Technology.

  • Group One Trading's largest Q3 2016 buy was Pfizer: 313,934 shares worth $10.1M.
  • Group One Trading added most to Humana in Q3 2016, an estimated $33M increase.
  • Group One Trading's biggest Q3 2016 reduction was Allergan plc, cutting an estimated $28.1M.
  • Group One Trading fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $22.3M.
  • Group One Trading's ten largest holdings make up 11% of its $9.21B portfolio in Q3 2016.
  • Group One Trading opened 864 new positions and closed 949 in Q3 2016.
  • Group One Trading's portfolio value rose 9% quarter-over-quarter to $9.21B.

Based on Group One Trading's 13F filing for Q3 2016, filed 14 Nov 2016.